Please login or register first to view this content.
Musculoskeletal Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
January 2023 Recap: Drug Pipeline Updates
Belimumab Granted Orphan Drug Status for Systemic Sclerosis
Turalio Dosing Regimen Updated for Tenosynovial Giant Cell Tumor
Amjevita, a Biosimilar to Humira, Now Available
High-Dose Exercise No Better Than Low-Dose Exercise for Knee Osteoarthritis
Aspirin Noninferior to Low-Molecular-Weight Heparin After Fracture
Antibody Oligonucleotide Conjugate Fast Tracked for Facioscapulohumeral Muscular Dystrophy
Prostate Cancer ADT Increases Bone Fracture Risk
Risankizumab Safe, Effective at 52 Weeks for Psoriatic Arthritis
December 2022: Notable Drug Approvals
Vamorolone Under Review for Duchenne Muscular Dystrophy
ACP Updates Living Guideline on Pharmacologic Treatment of Osteoporosis
Best Diets According to the Experts: 2023 Rankings Revealed
Noninvasive Interventions Can Reduce Spine Pain Versus Usual Care
Metformin Use Linked to Lower Risk for Joint Replacement in T2DM
Idacio, a Citrate-Free Biosimilar to Humira, Gets FDA Approval
Vitamin D No Aid for Statin-Associated Muscle Symptoms
Addition of Immunomodulators Cuts Vascular Inflammation in RA